- 32 -                                         
          issuance to petitioner of 7,650,000 shares--51 percent of the new           
          common stock of Endotronics5--as consideration for petitioner’s             
               4(...continued)                                                        
          368(a)(1)(G) as:                                                            
               a transfer by a corporation of all or part of its                      
               assets to another corporation in a title 11 or similar                 
               case; but only if, in pursuance of the plan, stock or                  
               securities of the corporation to which the assets are                  
               transferred are distributed in a transaction which                     
               qualifies under section 354, 355, or 356.                              
          An operative requirement of both (E) and (G) reorganizations is             
          an exchange of stock or securities.  In this case there was no              
          such exchange.  Petitioner received the stock of Endotronics as             
          compensation for providing services; petitioner did not transfer            
          any stock or securities in itself or of any other corporation in            
          exchange for the Endotronics shares.                                        
               5 The premier treatise on venture capital does not discuss             
          the factual situation presented by the Venture Funding, Ltd.                
          acquisition of control of Endotronics.  See Levin, Structuring              
          Venture Capital, Private Equity, and Entrepreneurial Transactions           
          (1997), especially ch. 8, Structuring a Turn-Around Investment in           
          an Overleveraged or Troubled Company.  The role of the venture              
          capitalist (VC) in the example described in ch. 8, see Levin,               
          supra at 264-265, is to contribute $8 million in new money to               
          “Badco” and to receive in exchange (while preexisting creditors             
          and shareholders are suffering various “haircuts”):                         
               $7.9 million face of new senior preferred stock,                       
               mandatorily redeemable 10 years after issuance, plus                   
               1,000 new common shares (at a stated price of $100 per                 
               common share, i.e., an aggregate of $0.1 million).                     
               [Levin, supra, sec. 802.1.1 at 264.]                                   
          Under the facts of the example, the new common shares received by           
          VC (1,000 out of 3,950) amount to 25 percent of Badco’s post                
          restructuring common stock.  It goes without saying that the                
          exchange of cash by VC for newly issued preferred and common                
          stock of Badco is a nontaxable transaction to both of them.  No             
          gain or loss is realized by (much less recognized to), either               
          party to the transaction, and the only obvious tax question                 
                                                             (continued...)           
Page:  Previous   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   NextLast modified: May 25, 2011